Even those who switched from the placebo saw improvement
Even those who received the placebo at first and then switched to the clemastine fumarate had consistent responses.
The team watched over each group when taking the drug, and found that the neural signal that leads from the eye all the way to the back of the brain was directly impacted. They found this reaction to be particularly accelerated when compared to the baseline taken before the start of the study. Not only did this reaction occur in those who were initially taking the drug, but also those who had switched to placebo; what this means is that the regeneration of myelin is not only accessible during current use of the drug, but has long-lasting effects, making the antihistamine even more potent against multiple sclerosis.